​

CRISPR gene editing is a topic in the health domain with significant developments in policy, regulation, and public health impact.

Key developments include crispr makes prostate cancer vulnerable to immunotherapy in mice, intellia reports positive pivotal trial results for crispr-based treatment of rare swelling disease, caribou biosciences halts car-t programs and seeks strategic alternatives after failing to secure funding, among other significant events and policy changes.

Source: Geo Health Space